Journal article icon

Journal article

Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren’s disease: Repurposing Anti-TNF for Treating Dupuytren’s Disease (RIDD)

Abstract:

Dupuytren’s disease (DD) is a common fibroproliferative condition of the palmar and digital fascia of the hand; however, there is currently no approved treatment for early stage DD. The objective of this paper is to describe the methods applied to assess the cost-effectiveness of adalimumab injections compared to usual care for controlling the progression of early stage DD in the Repurposing Anti-TNF for Treating Dupuytren’s Disease (RIDD) trial. Measure of effectiveness and resource use will...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.12688/wellcomeopenres.14936.2

Authors


More by this author
Institution:
University of Oxford
Department:
NDORMS
Role:
Author
More by this author
Institution:
University of Oxford
Department:
NDORMS
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Nuffield Department of Population Health
Sub department:
Population Health
Role:
Author
ORCID:
0000-0003-0239-7278
More by this author
Institution:
University of Oxford
Department:
NDORMS
Role:
Author
ORCID:
0000-0002-4723-5128
More by this author
Institution:
University of Oxford
Department:
Nuffield Department of Population Health
Role:
Author
Publisher:
F1000Research
Journal:
Wellcome Open Research More from this journal
Volume:
3
Article number:
156
Publication date:
2019-02-12
Acceptance date:
2019-01-13
DOI:
EISSN:
2398-502X
Keywords:
Pubs id:
pubs:951452
UUID:
uuid:a864510f-9375-4e3b-be46-4821b3ced20d
Local pid:
pubs:951452
Source identifiers:
951452
Deposit date:
2019-03-06

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP